Identification and Characterization of the Wilms Tumor Cancer Stem Cell
Overview
Authors
Affiliations
A nephrogenic progenitor cell (NP) with cancer stem cell characteristics driving Wilms tumor (WT) using spatial transcriptomics, bulk and single cell RNA sequencing, and complementary in vitro and transplantation experiments is identified and characterized. NP from WT samples with NP from the developing human kidney is compared. Cells expressing SIX2 and CITED1 fulfill cancer stem cell criteria by reliably recapitulating WT in transplantation studies. It is shown that self-renewal versus differentiation in SIX2+CITED1+ cells is regulated by the interplay between integrins ITGβ1 and ITGβ4. The spatial transcriptomic analysis defines gene expression maps of SIX2+CITED1+ cells in WT samples and identifies the interactive gene networks involved in WT development. These studies define SIX2+CITED1+ cells as the nephrogenic-like cancer stem cells of WT and points to the renal developmental transcriptome changes as a possible driver in regulating WT formation and progression.
Detection of Cancer Stem Cells from Patient Samples.
Hakala S, Hamalainen A, Sandelin S, Giannareas N, Narva E Cells. 2025; 14(2).
PMID: 39851576 PMC: 11764358. DOI: 10.3390/cells14020148.
A protracted war against cancer drug resistance.
Tian Y, Wang X, Wu C, Qiao J, Jin H, Li H Cancer Cell Int. 2024; 24(1):326.
PMID: 39342202 PMC: 11439304. DOI: 10.1186/s12935-024-03510-2.
Song L, Li Q, Xia L, Sahay A, Qiu Q, Li Y Nat Commun. 2024; 15(1):5937.
PMID: 39009564 PMC: 11250843. DOI: 10.1038/s41467-024-50171-w.
Roles and signaling pathways of CITED1 in tumors: overview and novel insights.
Chen W, Jiang J, Gao J, Wang G, Wang R, Lv J J Int Med Res. 2024; 52(1):3000605231220890.
PMID: 38190845 PMC: 10775745. DOI: 10.1177/03000605231220890.
Identification and Characterization of the Wilms Tumor Cancer Stem Cell.
Petrosyan A, Villani V, Aguiari P, Thornton M, Wang Y, Rajewski A Adv Sci (Weinh). 2023; 10(20):e2206787.
PMID: 37114795 PMC: 10369255. DOI: 10.1002/advs.202206787.